STOCKHOLM, May 28, 2024 /PRNewswire/ Calliditas Therapeutics AB , today announced the presentations of an additional efficacy analysis of Nefecon delayed release capsules)) as well as a.
Calliditas's interim report for the first quarter, January - March 2024 will be published in Swedish and English on Thursday 23 May 2024 at 07.00 a.m. CET.
A combined audio cast and telephone conference with the opportunity to ask questions will be.
Calliditas s interim report for the first quarter, January - March 2024 will be published in Swedish and English on Thursday 23 May 2024 at 07.00 a.m. CET.
A combined audio cast and telephone.